谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

ESR1 Gene Amplification and MAP3K Mutations Are Selected During Adjuvant Endocrine Therapies in Relapsing Hormone Receptor-positive, HER2-negative Breast Cancer (HR+ HER2- BC).

Lorenzo Ferrando,Andrea Vingiani,Anna Garuti,Claudio Vernieri,Antonino Belfiore,Luca Agnelli,Gianpaolo Dagrada,Diana Ivanoiu,Giuseppina Bonizzi,Elisabetta Munzone,Luana Lippolis,Martina Dameri,Francesco Ravera,Marco Colleoni,Giuseppe Viale,Luca Magnani,Alberto J. Ballestrero,Gabriele J. Zoppoli,Giancarlo J. Pruneri

PLOS GENETICS（2023）

引用 5|浏览67
暂无评分
关键词
Metastatic Breast Cancer,HER2,Breast Cancer,Hormone Receptors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要